StockData
Sangamo Therapeutics, Inc logo

Sangamo Therapeutics, Inc (SGMOQ) stock

SGMOQOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 14, 2026Score 4/30
$0.10−0.01 (-8.17%)

Close on Oct 19, 2026Market cap $39.43MP/E –Yield –

Sangamo Therapeutics statistics

40 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Mar 31, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
51.9%
10.8%
Float
410M
49M
Shares Held by Insiders
1.12%
11.6%
Shares Held by Institutions
0.13%
56.4%

MarginsIndustry

Operating Margin
-357.5%
-38.7%
Pretax Margin
-358.9%
-11.6%
Profit Margin
-356.9%
-31.6%
EBITDA Margin
-347.0%
-27.7%
FCF Margin
-261.8%
-9.56%

Returns on capitalIndustry

Return on Assets (ROA)
-168.8%
-40.6%
Return on Capital Employed (ROCE)
-1808.8%
-38.0%

Financial positionIndustry

Current Ratio
0.70
3.30
Quick Ratio
0.54
2.39

GrowthIndustry

Revenue Growth (YoY)
-45.8%
6.82%
Revenue Growth (3Y CAGR)
-29.2%
2.25%
Revenue Growth (5Y CAGR)
-19.7%
6.41%

EfficiencyIndustry

Asset Turnover
0.47
0.40
Revenue Per Employee
$243.36K
$429.29K
Profits Per Employee
-$868.52K
-$690.06K
Employee Count
142
75

Income statement (TTM)Industry

Revenue
$34.56M
$66.37M
Operating Income
-$123.56M
-$21.40M
Pretax Income
-$124.02M
-$12.98M
Net Income
-$123.33M
-$22.39M
EBITDA
-$119.90M
-$17.04M
EPS (Diluted)
-$0.38
-$0.76

Balance sheetIndustry

Net Cash (Debt)
$27.59M
$17.80M
Net Cash Per Share
$0.07
$0.80
Equity (Book Value)
-$18.96M
$53.27M
Book Value Per Share
-$0.05
$1.50
Tangible Book Value
-$18.96M
$26.82M
Working Capital
-$16.02M
$79.93M

Cash flow (TTM)Industry

Operating Cash Flow
-$90.34M
-$12.35M
Capital Expenditures
-$115.00K
-$1.00M
Free Cash Flow
-$90.46M
-$18.21M
FCF Per Share
-$0.22
-$0.42

Taxes and interestIndustry

Income Tax
-$687.00K
$73.00K

Scores and fair valueIndustry

Piotroski F-Score
2
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodSGMOQS&P 500DifferenceSGMOQ per yearS&P 500 per year
1 month-30.2%+0.6%−30.8 pts
3 months+55.7%+3.4%+52.3 pts
Year to date-75.9%+13.3%−89.2 pts
1 year-84.2%+16.6%−100.8 pts
3 years-80.9%+86.4%−167.3 pts-42.4%+23.1%
5 years-98.8%+81.9%−180.7 pts-58.8%+12.7%
10 years-97.2%+318.9%−416.0 pts-30.0%+15.4%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

8M SGMOQ shares were sold short on Oct 30, 2026, down 2.1% from the previous report. At recent volumes it would take 4.9 days to buy them back.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20268,348,367-2.1%1,705,8324.9
Oct 15, 20268,523,810-8.5%3,352,9252.5
Sep 30, 20269,314,967-13.1%2,790,7153.3
Sep 15, 202610,719,405+2.8%3,318,8793.2
Aug 31, 202610,425,868+4.9%6,187,0161.7
Aug 14, 20269,936,467-3.9%8,653,3591.1
Jul 31, 202610,336,148-1.3%4,543,7602.3
Jul 15, 202610,477,351-34.1%7,949,5831.3
Jun 30, 202615,896,609-35.8%24,284,7491.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?